Heather Raymon

Corporate Officer/Principal at Artiva Biotherapeutics, Inc.

Health Technology

Consumer Services

Profile

Heather Raymon is currently the SVP-Research & Early Development at Artiva Biotherapeutics, Inc. Prior to this, she worked as the Executive Director-Early Development Program at Bristol Myers Squibb Co. and as the Senior Director & Head-Pharmacology at Celgene Corp.
Dr. Raymon received her undergraduate degree from the State University of New York at Albany and her doctorate degree from the University of California, Irvine.

Heather Raymon active positions

Companies	Position	Start
Artiva Biotherapeutics, Inc. Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA.	Corporate Officer/Principal	30/09/2020

All active positions of Heather Raymon

Former positions of Heather Raymon

Companies	Position	End
CELGENE	Corporate Officer/Principal	-
BRISTOL-MYERS SQUIBB COMPANY	Corporate Officer/Principal	-

See the detail of Heather Raymon's experience

Training of Heather Raymon

State University of New York at Albany	Undergraduate Degree
University of California, Irvine	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Heather Raymon's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
BRISTOL-MYERS SQUIBB COMPANY	Health Technology

Private companies	2
Artiva Biotherapeutics, Inc. Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA.	Health Technology
Celgene Corp. Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.	Health Technology